BIO-Key Stock Executives


USD 0.92  0.08  8.00%   

BIO-Key International employes about 51 people. The company is managed by 20 executives with total tenure of roughly 140 years, averaging almost 7.0 years of service per executive having 2.55 employees per reported executive. Examination of BIO-Key International management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with BIO-Key International future performance.
Continue to Trending Equities.
  Kwok Wong  Chairman
MD ViceChairman
  Michael DePasquale  Chairman
Chairman, CEO and Pres

BIO-Key International Management Team Effectiveness

BIO-Key International has return on total asset (ROA) of (0.2422) % which means that it has lost $0.2422 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.4977) %, meaning that it created substantial loss on money invested by shareholders. BIO-Key International management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

BIO-Key International Workforce Comparison

BIO-Key International is rated below average in number of employees category among related companies. The total workforce of Information Technology industry is currently estimated at about 231,670. BIO-Key International adds roughly 51.0 in number of employees claiming only tiny portion of equities under Information Technology industry.

BIO-Key International Profit Margins

The company has Profit Margin (PM) of (1.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.01.

BIO-Key International Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO-Key International insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO-Key International's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIO-Key International insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BIO-Key International Benchmark Summation

The output start index for this execution was zero with a total number of output elements of sixty-one. BIO-Key International Price Series Summation is a cross summation of BIO-Key International price series and its benchmark/peer.

BIO-Key International Notable Stakeholders

A BIO-Key International stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIO-Key International often face trade-offs trying to please all of them. BIO-Key International's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIO-Key International's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kwok Wong - MD ViceChairmanProfile
Michael DePasquale - Chairman, CEO and PresProfile
Pieter Knook - DirectorProfile
Thomas Gilley - DirectorProfile
Jianhui Yau - DirectorProfile
Thomas Bush - DirectorProfile
Fabian Shin - DirectorProfile
Robert Michel - DirectorProfile
Charles Romeo - Independent DirectorProfile
John Schoenherr - Independent DirectorProfile
Barbara Rivera - DirectorProfile
Scott Mahnken - VP of MarketingProfile
Renat Zhdanov - Chief Scientist and VPProfile
Mark Cochran - Pres PortalGuardProfile
Cecilia Welch - Chief OfficerProfile
Akintunde Jeje - Managing AfricaProfile
Alex Rocha - Managing EMEAProfile
Frederick Corsentino - Chief Revenue OfficerProfile
James Sullivan - VP OfficerProfile
Mira LaCous - Chief OfficerProfile

About BIO-Key International Management Performance

The success or failure of an entity such as BIO-Key International often depends on how effective the management is. BIO-Key International management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIO-Key management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIO-Key management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
The data published in BIO-Key International's official financial statements usually reflect BIO-Key International's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BIO-Key International. For example, before you start analyzing numbers published by BIO-Key accountants, it's critical to develop an understanding of what BIO-Key International's liquidity, profitability, and earnings quality are in the context of the Software space in which it operates.
Please note, the presentation of BIO-Key International's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BIO-Key International's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BIO-Key International's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BIO-Key International. Please utilize our Beneish M Score to check the likelihood of BIO-Key International's management to manipulate its earnings.

BIO-Key International Workforce Analysis

Traditionally, organizations such as BIO-Key International use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIO-Key International within its industry.

BIO-Key International Manpower Efficiency

Return on BIO-Key International Manpower

Revenue Per Employee100.3 K
Revenue Per Executive255.7 K
Net Loss Per Employee99.3 K
Net Loss Per Executive253.3 K
Working Capital Per Employee160 K
Working Capital Per Executive408.1 K
Continue to Trending Equities. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for analysis

When running BIO-Key International price analysis, check to measure BIO-Key International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO-Key International is operating at the current time. Most of BIO-Key International's value examination focuses on studying past and present price action to predict the probability of BIO-Key International's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO-Key International's price. Additionally, you may evaluate how the addition of BIO-Key International to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is BIO-Key International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO-Key International. If investors know BIO-Key will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO-Key International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of BIO-Key International is measured differently than its book value, which is the value of BIO-Key that is recorded on the company's balance sheet. Investors also form their own opinion of BIO-Key International's value that differs from its market value or its book value, called intrinsic value, which is BIO-Key International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO-Key International's market value can be influenced by many factors that don't directly affect BIO-Key International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO-Key International's value and its price as these two are different measures arrived at by different means. Investors typically determine BIO-Key International value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO-Key International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.